Anna K Greenwood
Overview
Explore the profile of Anna K Greenwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
532
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reddy J, Heath L, Linden A, Allen M, de Paiva Lopes K, Seifar F, et al.
Alzheimers Dement
. 2024 Aug;
20(10):7174-7192.
PMID: 39215503
Introduction: Multi-omics studies in Alzheimer's disease (AD) revealed many potential disease pathways and therapeutic targets. Despite their promise of precision medicine, these studies lacked Black Americans (BA) and Latin Americans...
2.
Reddy J, Heath L, Linden A, Allen M, de Paiva Lopes K, Seifar F, et al.
bioRxiv
. 2024 Apr;
PMID: 38659743
Introduction: Multi-omics studies in Alzheimer's disease (AD) revealed many potential disease pathways and therapeutic targets. Despite their promise of precision medicine, these studies lacked African Americans (AA) and Latin Americans...
3.
Cary G, Wiley J, Gockley J, Keegan S, Amirtha Ganesh S, Heath L, et al.
Alzheimers Dement (N Y)
. 2024 Apr;
10(2):e12461.
PMID: 38650747
Introduction: Alzheimer's disease (AD) is the predominant dementia globally, with heterogeneous presentation and penetrance of clinical symptoms, variable presence of mixed pathologies, potential disease subtypes, and numerous associated endophenotypes. Beyond...
4.
Axtman A, Brennan P, Frappier-Brinton T, Betarbet R, Carter G, Fu H, et al.
Alzheimers Dement (N Y)
. 2023 May;
9(2):e12394.
PMID: 37215505
Alzheimer's disease (AD) drug discovery has focused on a set of highly studied therapeutic hypotheses, with limited success. The heterogeneous nature of AD processes suggests that a more diverse, systems-integrated...
5.
Quinney S, Murugesh K, Oblak A, Onos K, Sasner M, Greenwood A, et al.
Alzheimers Dement
. 2023 May;
19(11):5289-5295.
PMID: 37157089
We propose an unbiased methodology to rank compounds for advancement into comprehensive preclinical testing for Alzheimer's disease (AD). Translation of compounds to the clinic in AD has been hampered by...
6.
Thompson K, Peichel C, Rennison D, McGee M, Albert A, Vines T, et al.
PLoS Biol
. 2022 Jan;
20(1):e3001469.
PMID: 35007278
Hybrid incompatibilities occur when interactions between opposite ancestry alleles at different loci reduce the fitness of hybrids. Most work on incompatibilities has focused on those that are "intrinsic," meaning they...
7.
Gockley J, Montgomery K, Poehlman W, Wiley J, Liu Y, Gerasimov E, et al.
Genome Med
. 2021 May;
13(1):76.
PMID: 33947463
Background: Alzheimer's disease (AD) is an incurable neurodegenerative disease currently affecting 1.75% of the US population, with projected growth to 3.46% by 2050. Identifying common genetic variants driving differences in...
8.
Mukherjee S, Heath L, Preuss C, Jayadev S, Garden G, Greenwood A, et al.
Nat Commun
. 2020 Dec;
11(1):6307.
PMID: 33273466
A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20261-6.
9.
Mukherjee S, Heath L, Preuss C, Jayadev S, Garden G, Greenwood A, et al.
Nat Commun
. 2020 Nov;
11(1):5781.
PMID: 33188183
The temporal molecular changes that lead to disease onset and progression in Alzheimer's disease (AD) are still unknown. Here we develop a temporal model for these unobserved molecular changes with...
10.
Greenwood A, Montgomery K, Kauer N, Woo K, Leanza Z, Poehlman W, et al.
Curr Protoc Hum Genet
. 2020 Oct;
108(1):e105.
PMID: 33085189
The AD Knowledge Portal (adknowledgeportal.org) is a public data repository that shares data and other resources generated by multiple collaborative research programs focused on aging, dementia, and Alzheimer's disease (AD)....